Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.49 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3388061 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL248361 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL26135477 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL12086406 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL15987982 | 0.92 | ALDH1A1 (0.65) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL116765 | 0.92 | ALDH1A1 (0.65) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL943408 | 0.92 | ALDH1A1 (0.65) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL4582819 | 0.92 | ALDH1A1 (0.65) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL23196491 | 0.91 | ALDH1A1 (0.60) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL888164 | 0.91 | ALDH1A1 (0.60) | ALDH1A1LMNAKDM4EAPOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197183-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| US-20240197222-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| EP-4347761-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| EP-4347760-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| WO-2022234154-A1 | ORAL CARE FLAVOUR FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| WO-2022234153-A1 | ORAL CARE FLAVOUR FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2022-11-10 | — | — | WO | claimed |
| US-20140227342-A1 | ACETYLCHOLINESTERASE INHIBITOR COMPOSITION FOR SEXUAL USE | SMARTEK INTERNATIONAL, INC. | 2014-08-14 | — | — | US | claimed |
| EP-1121927-B1 | A composition causing different skin sensations | TAKASAGO PERFUMERY CO LTD (JP) | 2010-12-08 | — | — | EP | claimed |
| US-20070190090-A1 | SIALAGOGUE BASED ORAL CARE PRODUCTS | WHITEHILL ORAL TECHNOLOGIES, INC. (US) | 2007-08-16 | — | — | US | claimed |
| US-20060177384-A1 | Sialagogue coatings for interproximal devices | WHITEHILL ORAL TECHNOLOGIES, INC. | 2006-08-10 | — | — | US | claimed |
| US-6956139-B2 | (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-10-18 | — | — | US | claimed |
| US-6890567-B2 | Sensate composition imparting initial sensation upon contact | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-05-10 | — | — | US | claimed |
| US-6780443-B1 | COMBINATION OF COOLING, WARMING AND TINGLING AGENTS FOR SUCH AS MOUTHWASHES; EMPLOYS JAMBU OLEORESIN AND/OR SPILANTHOL; LONG LASTING | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-08-24 | — | — | US | claimed |
| US-20030215532-A1 | New sensate composition imparting initial sensation upon contact | TAKASAGO INTERNATIONAL CORPORATION | 2003-11-20 | — | — | US | claimed |
| US-20020198412-A1 | (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate | GREEN CARTER B (US) | 2002-12-26 | — | — | US | claimed |
| EP-1121927-A2 | A composition causing different skin sensations | Takasago International Corporation (JP) | 2001-08-08 | — | — | EP | claimed |
| US-12601929-B2 | Contact lens | COOPERVISION INTERNATIONAL LIMITED (GB) | 2026-04-14 | — | — | US | disclosed |
| EP-4717253-A2 | ORAL CARE COMPOSITIONS COMPRISING FLUORIDE IONS | The Procter & Gamble Company (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-1121927-A2 | A composition causing different skin sensations | Takasago International Corporation (JP) | 2001-08-08 | — | — | EP | disclosed |
| EP-1122233-A1 | A (1'R, 2'S, 5'R)-3-l-menthoxyalkan-1-ol cooling sensate | Takasago International Corporation (JP) | 2001-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190090-A1 | SIALAGOGUE BASED ORAL CARE PRODUCTS | MUC1, TAS2R40, TAS2R39 | ALDH1A1 3787/4885LMNA 4662/4885KDM4E 4690/4885 |
| US-12601929-B2 | Contact lens | TRPM8, TRPM7, TRPM5 | ALDH1A1 4075/4885LMNA 1959/4885KDM4E 1524/4885 |
| US-20020198412-A1 | (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate | TAS1R1, TAS2R1, TAS1R3 | ALDH1A1 76/4885LMNA 3297/4885KDM4E 2626/4885 |
| US-20030215532-A1 | New sensate composition imparting initial sensation upon contact | NISCH, OSBP, TRPA1 | ALDH1A1 2579/4885LMNA 4568/4885KDM4E 4507/4885 |
| US-20140227342-A1 | ACETYLCHOLINESTERASE INHIBITOR COMPOSITION FOR SEXUAL USE | ACHE, BCHE, SLC18A3 | ALDH1A1 437/4885LMNA 3417/4885KDM4E 1861/4885 |
| US-20060177384-A1 | Sialagogue coatings for interproximal devices | TAS2R10, SIGLEC7, TAS2R16 | ALDH1A1 3938/4885LMNA 4433/4885KDM4E 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.